← Leaderboards
Marian L Waterman
University Of California Irvine
$14,719,777
Attributed
$18,348,399
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,060,896 · 14
By mechanism
U54$11,669,828 · 2
R01$11,583,835 · 7
P30$3,280,344 · 2
R25$1,013,319 · 1
R21$359,070 · 1
R03$154,500 · 1
Top collaborators
- John Lowengrub11 shared
- Robert Andrew Edwards5 shared
- Klemens J Hertel5 shared
- Arthur D Lander5 shared
- Yongsheng Shi5 shared
- Peter John Donovan4 shared
- Steven Carl George2 shared
- Christopher C. W. Hughes2 shared
Most similar at University Of California Irvine
Same institution · by research overlap
- Arthur D Lander$24,994,474
- Vasan Venugopalan$6,162,004
- Randall F Holcombe$5,463,874
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCancer CellGrowthSignal TransductionCellsMemberFamilyComplexRegulationPatternGene ExpressionColon CarcinomaTranscription FactorGenesBaseTumorigenesisTcf Transcription FactorProtein IsoformsProgramsPhenotypeMolecularResearch StudyTumorPathway Interactions
Grant awards (61)
Shared Resource Management$829,471
P30 · FY2025 · CA · contact PI
Shared Resource Management$813,712
P30 · FY2024 · CA · contact PI
Shared Resource Management$818,659
P30 · FY2023 · CA · contact PI
Complexity, Cooperation and Community in Cancer$1,879,083
U54 · FY2022 · CA
Shared Resource Management$818,502
P30 · FY2022 · CA · contact PI
Circadian Clock and Myc-dependent Regulation of Cellular Transformation$587,441
R01 · FY2022 · CA
Project 1: Patterned Heterogeneity in Colon Cancer$385,689
U54 · FY2022 · CA · contact PI
A Short Course in Cancer Systems Biology$117,636
R25 · FY2022 · CA · contact PI
Complexity, Cooperation and Community in Cancer$2,087,357
U54 · FY2021 · CA
Project 1: Patterned Heterogeneity in Colon Cancer$440,558
U54 · FY2021 · CA · contact PI
A Short Course in Cancer Systems Biology$236,835
R25 · FY2021 · CA · contact PI
Complexity, Cooperation and Community in Cancer$1,899,177
U54 · FY2020 · CA
Project 1: Patterned Heterogeneity in Colon Cancer$404,554
U54 · FY2020 · CA · contact PI
Therapeutic targeting of Wnt & Metabolism in Colon Cancer$77,250
R03 · FY2020 · CA · contact PI
A Short Course in Cancer Systems Biology$5,220
R25 · FY2020 · CA · contact PI
Complexity, Cooperation and Community in Cancer$1,859,909
U54 · FY2019 · CA
Project 1: Patterned Heterogeneity in Colon Cancer$395,367
U54 · FY2019 · CA · contact PI
A Short Course in Cancer Systems Biology$174,740
R25 · FY2019 · CA · contact PI
Therapeutic targeting of Wnt & Metabolism in Colon Cancer$77,250
R03 · FY2019 · CA · contact PI
Complexity, Cooperation and Community in Cancer$1,986,971
U54 · FY2018 · CA
Coordinated regulation of alternative pre-mRNA processing in colon cancer$475,840
R01 · FY2018 · CA
Project 1: Patterned Heterogeneity in Colon Cancer$331,163
U54 · FY2018 · CA · contact PI
A Short Course in Cancer Systems Biology$239,444
R25 · FY2018 · CA · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$475,840
R01 · FY2017 · CA
TCF3: A Wnt Pathway Effector in Pluripotent Stem Cell Self-Renewal$277,920
R01 · FY2017 · GM
A Short Course in Cancer Systems Biology$239,444
R25 · FY2017 · CA · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$475,840
R01 · FY2016 · CA
TCF3: A Wnt Pathway Effector in Pluripotent Stem Cell Self-Renewal$278,806
R01 · FY2016 · GM
Coordinated regulation of alternative pre-mRNA processing in colon cancer$472,634
R01 · FY2015 · CA
Wnt Signaling in Colon Cancer$286,517
R01 · FY2015 · CA · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$469,833
R01 · FY2014 · CA
TCF3: A Wnt Pathway Effector in Pluripotent Stem Cell Self-Renewal$279,551
R01 · FY2014 · GM
Wnt Signaling in Colon Cancer$277,921
R01 · FY2014 · CA · contact PI
A 3-D in vitro platform of tumor metastasis (PQ24)$318,879
R01 · FY2013 · CA
TCF3: A Wnt Pathway Effector in Pluripotent Stem Cell Self-Renewal$279,646
R01 · FY2013 · GM
Wnt Signaling in Colon Cancer$269,326
R01 · FY2013 · CA · contact PI
A 3-D in vitro platform of tumor metastasis (PQ24)$338,175
R01 · FY2012 · CA
Wnt Signaling in Colon Cancer$287,159
R01 · FY2012 · CA · contact PI
LEF/TCF Expression in colon cancer$257,995
R01 · FY2012 · CA · contact PI
Wnt Signaling in Colon Cancer$299,453
R01 · FY2011 · CA · contact PI
LEF/TCF Expression in colon cancer$257,995
R01 · FY2011 · CA · contact PI
LEF/TCF Expression in colon cancer$265,974
R01 · FY2010 · CA · contact PI
LEF-1 translation in chronic myelegenous leukemia$162,363
R21 · FY2010 · CA · contact PI
Wnt signaling in Colon Cancer$274,978
R01 · FY2009 · CA · contact PI
LEF/TCF Expression in colon cancer$265,829
R01 · FY2009 · CA · contact PI
LEF-1 translation in chronic myelegenous leukemia$196,707
R21 · FY2009 · CA · contact PI
Wnt signaling in Colon Cancer$276,029
R01 · FY2008 · CA · contact PI
LEF/TCF Expression in colon cancer$265,104
R01 · FY2008 · CA · contact PI
LEF/TCF Expression in Colon Cancer$250,249
R01 · FY2007 · CA · contact PI
Wnt signaling in Colon Cancer$248,417
R01 · FY2007 · CA · contact PI
LEF/TCF Expression in Colon Cancer$257,937
R01 · FY2006 · CA · contact PI
Wnt signaling in Colon Cancer$256,715
R01 · FY2006 · CA · contact PI
LEF/TCF Expression in Colon Cancer$296,475
R01 · FY2005 · CA
Wnt signaling in Colon Cancer$233,224
R01 · FY2005 · CA
ACTIVITIES OF BETA CATENIN AND LEF/TCF COMPLEXES$298,035
R01 · FY2004 · CA
LEF/TCF Expression in Colon Cancer$262,915
R01 · FY2004 · CA
LEF/TCF Expression in Colon Cancer$343,111
R01 · FY2003 · CA
ACTIVITIES OF BETA CATENIN AND LEF/TCF COMPLEXES$290,138
R01 · FY2003 · CA
ACTIVITIES OF BETA CATENIN AND LEF/TCF COMPLEXES$281,688
R01 · FY2002 · CA
ACTIVITIES OF BETA CATENIN AND LEF/TCF COMPLEXES$278,881
R01 · FY2001 · CA
ACTIVITIES OF BETA CATENIN AND LEF/TCF COMPLEXES$271,365
R01 · FY2000 · CA